Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey
Tzu Tsun Luk,Shengzhi Zhao,Yongda Wu,Man Ping Wang,Tai Hing Lam,Janet Yuen-ha Wong
DOI: https://doi.org/10.1016/j.vaccine.2021.05.036
IF: 4.169
2021-06-01
Vaccine
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Although vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most desired solution to end the coronavirus disease (COVID-19) pandemic, there are growing concerns that vaccine hesitancy would undermine its potential. We examined the intention to receive vaccination against SARS-CoV-2 and the associated factors in a representative sample of Chinese adults in Hong Kong.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We did a dual-frame (landline and mobile) cross-sectional survey of a random sample of 1501 Hong Kong residents aged 18 years or older (53.6% females) in April 2020. We collected data on the intention to receive SARS-CoV-2 vaccine when it becomes available (yes/ no/ undecided), knowledge and perceptions of COVID-19, smoking, alcohol drinking, and sociodemographic factors. Prevalence estimates were weighted by the sex, age, and education of the general population of Hong Kong.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Overall, 45.3% (95% CI: 42.3–48.4%) of the participants had intentions to vaccinate against SARS-CoV-2 when it becomes available, 29.2% (26.5–32.1%) were undecided, and 25.5% (22.9–28.2%) had no intention. The most common reason for vaccine hesitancy (undecided or no intention) was safety concerns (56.5%). Multivariable partial proportional odds model showed higher vaccine hesitancy in males, younger adults, those with no chronic disease, current smokers, and non-alcohol drinkers. After adjusting for sociodemographic and other factors, inadequate knowledge of SARS-CoV-2 transmission (adjusted ORs ranged from 1.27–2.63; P<.05) and lower perceived danger of COVID-19 (adjusted ORs ranged from 1.62–2.47; P<.001) were significantly associated with vaccine hesitancy.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>In a representative sample of Chinese adults in Hong Kong, only 45.3% of the participants intended to vaccinate against SARS-CoV-2 when available. Vaccine hesitancy was associated with inadequate knowledge about SARS-CoV-2 transmission and lower perceived danger of COVID-19, which needed to be addressed to improve vaccination uptake.</p>
immunology,medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to understand the prevalence of hesitancy (i.e., delaying or refusing vaccination) towards SARS - CoV - 2 vaccines among the population in Hong Kong and its determinants. Specifically, the study aims to:
1. **Evaluate the prevalence of SARS - CoV - 2 vaccine hesitancy**: Through a population - based survey, researchers hope to understand the proportions of Hong Kong residents who are willing to be vaccinated, hesitant, and unwilling to be vaccinated when the vaccine is available.
2. **Identify the factors influencing vaccine hesitancy**: Researchers hope to determine which factors are associated with a higher rate of vaccine hesitancy by analyzing participants' sociodemographic characteristics (such as gender, age, education level), chronic disease status, smoking and drinking habits, etc.
3. **Explore the reasons for vaccine hesitancy**: The study also investigated the specific reasons of those who indicated unwillingness or hesitation to be vaccinated, including concerns about side effects, believing that the vaccine is ineffective, thinking that there is no need to be vaccinated or having no time to be vaccinated, etc.
Through these objectives, researchers hope to be able to provide strategic suggestions for future vaccine promotion campaigns, especially for those hesitant populations, in order to increase vaccine acceptance and vaccination rates, thereby promoting the achievement of herd immunity.